Pathogenic and clinical significance of inflammation-associated MicroRNAs in cardiovascular diseases
- 22 September 2025
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-22
Abstract
Cardiovascular diseases (CVDs) include a spectrum of heart and blood vessel disorders e.g., atherosclerosis, hypertension, coronary artery disease, and peripheral artery disease, leading to global mortality. It is an established fact that inflammation significantly contributes to the pathogenesis of CVDs, acting as a risk factor and accelerating disease progression. miRNAs play a key role in this process. However, studying miRNAs in inflammation presents multiple challenges, including the regulation of multiple target genes by a single miRNA and the involvement of the same inflammatory miRNA in more than one type of CVD. In this review, we explored the role of miRNAs in regulating inflammation in different types of CVDs, including hypertension, coronary artery disease, and peripheral artery disease, along with their common target genes. These miRNAs serve as key regulators of inflammatory pathways by modulating cytokine production, immune cell recruitment, and endothelial cell function, thereby playing dual roles in promoting or mitigating inflammation. Several miRNAs play a pivotal role in inflammation, contributing to various CVDs. miR-155A and miR-146a regulate inflammatory pathways by targeting TNF-α, NF-κB, and IRAK1/TRAF6, linking them to atherosclerosis, myocardial infarction (MI), and acute coronary syndromes (ACS). miR-21 modulates TGF-βR1, PDCD4, and SMAD7, promoting fibrosis and vascular remodeling, which are associated with hypertension and heart failure. miR-221/222 influences vascular smooth muscle cell (VSMC) proliferation by targeting p27(Kip1) and JNK1/ETS-1, leading to neointimal hyperplasia and hypertension. Additionally, miR-133a/b regulates Notch signaling, contributing to atherosclerosis and cardiac fibrosis. These miRNAs serve as potential biomarkers and therapeutic targets for inflammation-driven CVDs.Keywords
This publication has 102 references indexed in Scilit:
- The miR‐181 family: Wide‐ranging pathophysiological effects on cell fate and functionJournal of Cellular Physiology, 2023
- miR-146a contributes to atherosclerotic plaque stability by regulating the expression of TRAF6 and IRAK-1Molecular Biology Reports, 2022
- The Influence of Bosentan on MicroRNA-27a/PPARγ/ET-1 Signaling Pathway in Pulmonary Artery HypertensionPediatric Cardiology, 2021
- The role of miRNA-155 in monocrotaline-induced pulmonary arterial hypertension through c-Fos/NLRP3/caspase-1Molecular & Cellular Toxicology, 2020
- miR‐181a/b‐5p ameliorates inflammatory response in monocrotaline‐induced pulmonary arterial hypertension by targeting endocanJournal of Cellular Physiology, 2019
- Retracted: Effects of microrna‐93 on mouse cardiac microvascular endothelial cells injury and inflammatory response by mediating SPP1 through the NF‐ΚB pathwayJournal of Cellular Biochemistry, 2017
- MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide productionBiochemical and Biophysical Research Communications, 2015
- miR-146a Polymorphism Influences Levels of miR-146a, IRAK-1, and TRAF-6 in Young Patients with Coronary Artery DiseaseCell Biochemistry and Biophysics, 2013
- A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarctionBiochemical and Biophysical Research Communications, 2012
- miR-155 gene: A typical multifunctional microRNABiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009